SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003260
Filing Date
2023-03-09
Accepted
2023-03-09 07:45:38
Documents
13
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230309x8k.htm   iXBRL 8-K 37340
2 EX-99.1 elev-20230309xex99d1.htm EX-99.1 139223
  Complete submission text file 0001558370-23-003260.txt   311536

Data Files

Seq Description Document Type Size
3 EX-101.SCH elev-20230309.xsd EX-101.SCH 3064
4 EX-101.LAB elev-20230309_lab.xml EX-101.LAB 16676
5 EX-101.PRE elev-20230309_pre.xml EX-101.PRE 10641
7 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230309x8k_htm.xml XML 4992
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 23718220
SIC: 2836 Biological Products, (No Diagnostic Substances)